Avendus Fund leads Rs 300 Cr investment in Aragen Life Sciences

Avendus Rs 300 crore bet on Aragen comes amid a surge in Indias CRDMO sector, as global pharma outsourcing accelerates and trade policy shifts raise questions over export exposure.